| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | 3'-phosphoadenosine 5'-phosphosulfate binding | 2.33e-09 | 13 | 92 | 5 | GO:0050656 | |
| GeneOntologyMolecularFunction | sulfate binding | 5.22e-08 | 9 | 92 | 4 | GO:0043199 | |
| GeneOntologyMolecularFunction | aryl sulfotransferase activity | 8.68e-08 | 10 | 92 | 4 | GO:0004062 | |
| GeneOntologyMolecularFunction | tyrosine-ester sulfotransferase activity | 3.77e-07 | 4 | 92 | 3 | GO:0017067 | |
| GeneOntologyMolecularFunction | amine sulfotransferase activity | 3.77e-07 | 4 | 92 | 3 | GO:0047685 | |
| GeneOntologyMolecularFunction | flavonol 3-sulfotransferase activity | 9.40e-07 | 5 | 92 | 3 | GO:0047894 | |
| GeneOntologyMolecularFunction | steroid sulfotransferase activity | 3.27e-06 | 7 | 92 | 3 | GO:0050294 | |
| GeneOntologyMolecularFunction | 20-hydroxy-leukotriene B4 omega oxidase activity | 2.10e-05 | 2 | 92 | 2 | GO:0097258 | |
| GeneOntologyMolecularFunction | 20-aldehyde-leukotriene B4 20-monooxygenase activity | 2.10e-05 | 2 | 92 | 2 | GO:0097259 | |
| GeneOntologyMolecularFunction | sulfotransferase activity | 1.20e-04 | 55 | 92 | 4 | GO:0008146 | |
| GeneOntologyMolecularFunction | alpha-tocopherol omega-hydroxylase activity | 2.08e-04 | 5 | 92 | 2 | GO:0052871 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 2.56e-04 | 27 | 92 | 3 | GO:0008391 | |
| GeneOntologyMolecularFunction | transferase activity, transferring sulphur-containing groups | 3.79e-04 | 74 | 92 | 4 | GO:0016782 | |
| GeneOntologyMolecularFunction | leukotriene-B4 20-monooxygenase activity | 4.34e-04 | 7 | 92 | 2 | GO:0050051 | |
| GeneOntologyMolecularFunction | alkane 1-monooxygenase activity | 4.34e-04 | 7 | 92 | 2 | GO:0018685 | |
| GeneOntologyMolecularFunction | aromatase activity | 5.57e-04 | 35 | 92 | 3 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 8.27e-04 | 40 | 92 | 3 | GO:0016709 | |
| GeneOntologyMolecularFunction | arachidonate omega-hydroxylase activity | 9.22e-04 | 10 | 92 | 2 | GO:0052869 | |
| GeneOntologyMolecularFunction | fatty acid omega-hydroxylase activity | 9.22e-04 | 10 | 92 | 2 | GO:0120250 | |
| GeneOntologyMolecularFunction | long-chain fatty acid omega-hydroxylase activity | 9.22e-04 | 10 | 92 | 2 | GO:0102033 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 1.05e-03 | 97 | 92 | 4 | GO:0008081 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.14e-03 | 562 | 92 | 9 | GO:0003712 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 1.50e-03 | 49 | 92 | 3 | GO:0016712 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen | 1.58e-03 | 13 | 92 | 2 | GO:0016713 | |
| GeneOntologyMolecularFunction | core promoter sequence-specific DNA binding | 2.09e-03 | 55 | 92 | 3 | GO:0001046 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 3.06e-03 | 18 | 92 | 2 | GO:0008569 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 3.81e-03 | 323 | 92 | 6 | GO:1901681 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | 3.86e-03 | 938 | 92 | 11 | GO:0016772 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 4.16e-03 | 229 | 92 | 5 | GO:0003714 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing S-S bonds | 4.57e-03 | 22 | 92 | 2 | GO:0016864 | |
| GeneOntologyMolecularFunction | protein disulfide isomerase activity | 4.57e-03 | 22 | 92 | 2 | GO:0003756 | |
| GeneOntologyBiologicalProcess | 3'-phosphoadenosine 5'-phosphosulfate metabolic process | 8.39e-09 | 17 | 90 | 5 | GO:0050427 | |
| GeneOntologyBiologicalProcess | purine ribonucleoside bisphosphate metabolic process | 8.39e-09 | 17 | 90 | 5 | GO:0034035 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 2.35e-07 | 13 | 90 | 4 | GO:0009812 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 7.72e-07 | 17 | 90 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 7.85e-07 | 73 | 90 | 6 | GO:1901616 | |
| GeneOntologyBiologicalProcess | 4-nitrophenol metabolic process | 7.98e-07 | 5 | 90 | 3 | GO:0018960 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 9.90e-07 | 18 | 90 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | xenobiotic metabolic process | 2.80e-06 | 141 | 90 | 7 | GO:0006805 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 2.82e-06 | 23 | 90 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | sulfation | 5.51e-06 | 27 | 90 | 4 | GO:0051923 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 7.01e-06 | 106 | 90 | 6 | GO:0034308 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | SULT1A4 CYP2D6 SULT1A1 SULT1A3 ENPP1 LPCAT3 CACNA1H CYP4F2 GPRC6A CYP4F3 SULT1C4 LDHB | 2.19e-05 | 641 | 90 | 12 | GO:1901615 |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 5.24e-05 | 47 | 90 | 4 | GO:0046164 | |
| GeneOntologyBiologicalProcess | cellular response to xenobiotic stimulus | 5.33e-05 | 222 | 90 | 7 | GO:0071466 | |
| GeneOntologyBiologicalProcess | regulation of branch elongation involved in ureteric bud branching | 5.63e-05 | 3 | 90 | 2 | GO:0072095 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 7.82e-05 | 52 | 90 | 4 | GO:0008210 | |
| GeneOntologyBiologicalProcess | branch elongation involved in ureteric bud branching | 1.12e-04 | 4 | 90 | 2 | GO:0060681 | |
| GeneOntologyBiologicalProcess | positive regulation of dendrite development | 1.17e-04 | 22 | 90 | 3 | GO:1900006 | |
| GeneOntologyBiologicalProcess | regulation of mesonephros development | 1.87e-04 | 5 | 90 | 2 | GO:0061217 | |
| GeneOntologyBiologicalProcess | steroid metabolic process | 2.39e-04 | 376 | 90 | 8 | GO:0008202 | |
| GeneOntologyBiologicalProcess | leukotriene B4 catabolic process | 2.79e-04 | 6 | 90 | 2 | GO:0036101 | |
| GeneOntologyBiologicalProcess | catechol-containing compound metabolic process | 3.09e-04 | 74 | 90 | 4 | GO:0009712 | |
| GeneOntologyBiologicalProcess | catecholamine metabolic process | 3.09e-04 | 74 | 90 | 4 | GO:0006584 | |
| GeneOntologyBiologicalProcess | leukotriene B4 metabolic process | 3.90e-04 | 7 | 90 | 2 | GO:0036102 | |
| GeneOntologyBiologicalProcess | nucleoside bisphosphate metabolic process | 3.96e-04 | 142 | 90 | 5 | GO:0033865 | |
| GeneOntologyBiologicalProcess | ribonucleoside bisphosphate metabolic process | 3.96e-04 | 142 | 90 | 5 | GO:0033875 | |
| GeneOntologyBiologicalProcess | purine nucleoside bisphosphate metabolic process | 3.96e-04 | 142 | 90 | 5 | GO:0034032 | |
| GeneOntologyBiologicalProcess | axon ensheathment in central nervous system | 3.99e-04 | 33 | 90 | 3 | GO:0032291 | |
| GeneOntologyBiologicalProcess | central nervous system myelination | 3.99e-04 | 33 | 90 | 3 | GO:0022010 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | 4.40e-04 | 412 | 90 | 8 | GO:0006066 | |
| GeneOntologyBiologicalProcess | leukotriene catabolic process | 5.18e-04 | 8 | 90 | 2 | GO:0036100 | |
| GeneOntologyBiologicalProcess | ureteric bud elongation | 5.18e-04 | 8 | 90 | 2 | GO:0060677 | |
| GeneOntologyBiologicalProcess | negative regulation of canonical Wnt signaling pathway | 5.74e-04 | 154 | 90 | 5 | GO:0090090 | |
| GeneOntologyBiologicalProcess | regulation of kidney development | 6.07e-04 | 38 | 90 | 3 | GO:0090183 | |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 6.08e-04 | 156 | 90 | 5 | GO:0032989 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 6.08e-04 | 156 | 90 | 5 | GO:0010927 | |
| GeneOntologyBiologicalProcess | central nervous system myelin formation | 6.64e-04 | 9 | 90 | 2 | GO:0032289 | |
| GeneOntologyBiologicalProcess | regulation of epithelial tube formation | 6.64e-04 | 9 | 90 | 2 | GO:1905276 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial tube formation | 6.64e-04 | 9 | 90 | 2 | GO:1905278 | |
| GeneOntologyCellularComponent | inner dynein arm | 9.68e-06 | 10 | 92 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.77e-04 | 25 | 92 | 3 | GO:0005858 | |
| HumanPheno | Abnormal blood cation concentration | 5.92e-06 | 401 | 29 | 11 | HP:0010929 | |
| HumanPheno | Abnormal blood ion concentration | 1.62e-05 | 445 | 29 | 11 | HP:0003111 | |
| HumanPheno | Abnormal blood inorganic cation concentration | 1.82e-05 | 216 | 29 | 8 | HP:0010927 | |
| HumanPheno | Spinal canal stenosis | 8.97e-05 | 43 | 29 | 4 | HP:0003416 | |
| HumanPheno | Upper limb metaphyseal widening | 9.36e-05 | 3 | 29 | 2 | HP:0003856 | |
| HumanPheno | Abnormal circulating calcium concentration | 9.98e-05 | 201 | 29 | 7 | HP:0004363 | |
| Domain | TLE_N | 2.63e-09 | 5 | 91 | 4 | PF03920 | |
| Domain | Groucho/TLE_N | 2.63e-09 | 5 | 91 | 4 | IPR005617 | |
| Domain | Groucho_enhance | 1.11e-06 | 5 | 91 | 3 | IPR009146 | |
| Domain | Sulfotransferase_dom | 2.76e-05 | 36 | 91 | 4 | IPR000863 | |
| Domain | Sulfotransfer_1 | 2.76e-05 | 36 | 91 | 4 | PF00685 | |
| Domain | TRPM_tetra | 1.40e-04 | 4 | 91 | 2 | IPR032415 | |
| Domain | TRPM_tetra | 1.40e-04 | 4 | 91 | 2 | PF16519 | |
| Domain | TPR_REGION | 1.56e-04 | 165 | 91 | 6 | PS50293 | |
| Domain | TPR | 1.56e-04 | 165 | 91 | 6 | PS50005 | |
| Domain | Prefoldin | 4.21e-04 | 72 | 91 | 4 | IPR009053 | |
| Domain | TPR_repeat | 4.84e-04 | 133 | 91 | 5 | IPR019734 | |
| Domain | SO | 8.27e-04 | 9 | 91 | 2 | SM00201 | |
| Domain | TPR-contain_dom | 8.35e-04 | 150 | 91 | 5 | IPR013026 | |
| Domain | - | 9.01e-04 | 39 | 91 | 3 | 2.120.10.30 | |
| Domain | Somatomedin_B_dom | 1.03e-03 | 10 | 91 | 2 | IPR001212 | |
| Domain | SMB_1 | 1.03e-03 | 10 | 91 | 2 | PS00524 | |
| Domain | SMB_2 | 1.03e-03 | 10 | 91 | 2 | PS50958 | |
| Domain | Cyt_P450_E_grp-I | 1.37e-03 | 45 | 91 | 3 | IPR002401 | |
| Domain | 6-blade_b-propeller_TolB-like | 1.46e-03 | 46 | 91 | 3 | IPR011042 | |
| Domain | WD40 | 1.99e-03 | 268 | 91 | 6 | SM00320 | |
| Domain | Dynein_heavy_chain_D4_dom | 2.06e-03 | 14 | 91 | 2 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 2.06e-03 | 14 | 91 | 2 | IPR013602 | |
| Domain | DHC_N2 | 2.06e-03 | 14 | 91 | 2 | PF08393 | |
| Domain | AAA_8 | 2.06e-03 | 14 | 91 | 2 | PF12780 | |
| Domain | ATPase_dyneun-rel_AAA | 2.06e-03 | 14 | 91 | 2 | IPR011704 | |
| Domain | AAA_5 | 2.06e-03 | 14 | 91 | 2 | PF07728 | |
| Domain | WD40_repeat | 2.14e-03 | 272 | 91 | 6 | IPR001680 | |
| Domain | Cyt_P450_CS | 2.20e-03 | 53 | 91 | 3 | IPR017972 | |
| Domain | DHC_fam | 2.37e-03 | 15 | 91 | 2 | IPR026983 | |
| Domain | Dynein_heavy_dom | 2.37e-03 | 15 | 91 | 2 | IPR004273 | |
| Domain | Dynein_heavy | 2.37e-03 | 15 | 91 | 2 | PF03028 | |
| Domain | WD_REPEATS_1 | 2.39e-03 | 278 | 91 | 6 | PS00678 | |
| Domain | WD_REPEATS_2 | 2.43e-03 | 279 | 91 | 6 | PS50082 | |
| Domain | WD_REPEATS_REGION | 2.43e-03 | 279 | 91 | 6 | PS50294 | |
| Domain | CYTOCHROME_P450 | 2.71e-03 | 57 | 91 | 3 | PS00086 | |
| Domain | - | 2.84e-03 | 58 | 91 | 3 | 1.10.630.10 | |
| Domain | p450 | 2.84e-03 | 58 | 91 | 3 | PF00067 | |
| Domain | Cyt_P450 | 3.13e-03 | 60 | 91 | 3 | IPR001128 | |
| Domain | WD40_repeat_dom | 3.31e-03 | 297 | 91 | 6 | IPR017986 | |
| Domain | - | 3.43e-03 | 207 | 91 | 5 | 1.25.40.10 | |
| Domain | GPCR_3 | 4.64e-03 | 21 | 91 | 2 | IPR000337 | |
| Domain | 7tm_3 | 5.09e-03 | 22 | 91 | 2 | PF00003 | |
| Domain | G_PROTEIN_RECEP_F3_2 | 5.09e-03 | 22 | 91 | 2 | PS00980 | |
| Domain | G_PROTEIN_RECEP_F3_3 | 5.09e-03 | 22 | 91 | 2 | PS00981 | |
| Domain | G_PROTEIN_RECEP_F3_1 | 5.09e-03 | 22 | 91 | 2 | PS00979 | |
| Domain | G_PROTEIN_RECEP_F3_4 | 5.09e-03 | 22 | 91 | 2 | PS50259 | |
| Domain | GPCR_3_C | 5.09e-03 | 22 | 91 | 2 | IPR017978 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 5.69e-07 | 14 | 71 | 4 | M27402 | |
| Pathway | KEGG_MEDICUS_ENV_FACTOR_PHIP_TO_DNA_ADDUCTS | 1.22e-06 | 5 | 71 | 3 | M47807 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 5.82e-06 | 24 | 71 | 4 | M16289 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.28e-05 | 29 | 71 | 4 | M45015 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.42e-05 | 220 | 71 | 8 | M10320 | |
| Pathway | REACTOME_REPRESSION_OF_WNT_TARGET_GENES | 1.43e-05 | 10 | 71 | 3 | MM15156 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 2.61e-05 | 12 | 71 | 3 | M27128 | |
| Pathway | KEGG_SULFUR_METABOLISM | 3.38e-05 | 13 | 71 | 3 | M18256 | |
| Pathway | REACTOME_FATTY_ACIDS | 5.33e-05 | 15 | 71 | 3 | M27126 | |
| Pathway | WP_SULFATION_BIOTRANSFORMATION_REACTION | 7.91e-05 | 17 | 71 | 3 | M39483 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 9.46e-05 | 18 | 71 | 3 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 9.46e-05 | 18 | 71 | 3 | MM14841 | |
| Pathway | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 9.72e-05 | 48 | 71 | 4 | M611 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | 1.14e-04 | 219 | 71 | 7 | MM14838 | |
| Pathway | WP_ESTROGEN_METABOLISM | 1.76e-04 | 22 | 71 | 3 | MM15888 | |
| Pathway | REACTOME_CYTOSOLIC_SULFONATION_OF_SMALL_MOLECULES | 2.02e-04 | 23 | 71 | 3 | MM14597 | |
| Pathway | REACTOME_DRUG_ADME | 2.19e-04 | 109 | 71 | 5 | M45012 | |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | 2.93e-04 | 26 | 71 | 3 | MM14793 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | 3.14e-04 | 183 | 71 | 6 | M39588 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 5.21e-04 | 74 | 71 | 4 | M616 | |
| Pathway | REACTOME_DEACTIVATION_OF_THE_BETA_CATENIN_TRANSACTIVATING_COMPLEX | 5.47e-04 | 32 | 71 | 3 | MM14975 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 7.68e-04 | 82 | 71 | 4 | MM15922 | |
| Pathway | REACTOME_DEGRADATION_OF_BETA_CATENIN_BY_THE_DESTRUCTION_COMPLEX | 8.80e-04 | 85 | 71 | 4 | M27079 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 9.82e-04 | 39 | 71 | 3 | MM15695 | |
| Pubmed | 2.39e-10 | 5 | 93 | 4 | 8365415 | ||
| Pubmed | 7.16e-10 | 6 | 93 | 4 | 8573724 | ||
| Pubmed | A Gro/TLE-NuRD corepressor complex facilitates Tbx20-dependent transcriptional repression. | 1.67e-09 | 7 | 93 | 4 | 24024827 | |
| Pubmed | Six3 and Six6 activity is modulated by members of the groucho family. | 3.33e-09 | 8 | 93 | 4 | 12441302 | |
| Pubmed | 3.33e-09 | 8 | 93 | 4 | 16002402 | ||
| Pubmed | Expression of Groucho/TLE proteins during pancreas development. | 5.01e-09 | 24 | 93 | 5 | 18778483 | |
| Pubmed | Ethanol sulfation by the human cytosolic sulfotransferases: a systematic analysis. | 5.97e-09 | 9 | 93 | 4 | 23207770 | |
| Pubmed | 9.94e-09 | 10 | 93 | 4 | 7601475 | ||
| Pubmed | KIAA0319 FOCAD PDS5B TENM4 ZBED4 TLE3 CACNA1H ZDHHC17 ULK2 ADCY2 ARHGAP21 | 1.27e-08 | 407 | 93 | 11 | 12693553 | |
| Pubmed | 1.56e-08 | 11 | 93 | 4 | 11154739 | ||
| Pubmed | Sulfation and sulfotransferases 1: Sulfotransferase molecular biology: cDNAs and genes. | 1.56e-08 | 11 | 93 | 4 | 9034160 | |
| Pubmed | 1.56e-08 | 11 | 93 | 4 | 10720750 | ||
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 8808280 | ||
| Pubmed | Sulphation of acetaminophen by the human cytosolic sulfotransferases: a systematic analysis. | 1.85e-08 | 3 | 93 | 3 | 26067475 | |
| Pubmed | Identification of two human brain aryl sulfotransferase cDNAs. | 1.85e-08 | 3 | 93 | 3 | 8363592 | |
| Pubmed | 1.85e-08 | 3 | 93 | 3 | 9855620 | ||
| Pubmed | All Tcf HMG box transcription factors interact with Groucho-related co-repressors. | 2.33e-08 | 12 | 93 | 4 | 11266540 | |
| Pubmed | Structural and chemical profiling of the human cytosolic sulfotransferases. | 3.36e-08 | 13 | 93 | 4 | 17425406 | |
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 24318996 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 8645603 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 33414449 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 8943792 | ||
| Pubmed | A single mutation converts the nucleotide specificity of phenol sulfotransferase from PAP to AMP. | 7.39e-08 | 4 | 93 | 3 | 12390022 | |
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 32152050 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 8424956 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 11290324 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 8288252 | ||
| Pubmed | 7.39e-08 | 4 | 93 | 3 | 25370010 | ||
| Pubmed | PRDI-BF1/Blimp-1 repression is mediated by corepressors of the Groucho family of proteins. | 7.39e-08 | 4 | 93 | 3 | 9887105 | |
| Pubmed | 1.42e-07 | 18 | 93 | 4 | 20056724 | ||
| Pubmed | UBR1 CEP85 ENPP1 BUB1 ELP1 ZDHHC17 EZH2 ANAPC5 GARRE1 ARHGAP21 CEMIP2 RFWD3 | 1.72e-07 | 650 | 93 | 12 | 38777146 | |
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 11389699 | ||
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 29908303 | ||
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 1303260 | ||
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 10748198 | ||
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 25053625 | ||
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 8989517 | ||
| Pubmed | 1.84e-07 | 5 | 93 | 3 | 24802129 | ||
| Pubmed | 3.68e-07 | 6 | 93 | 3 | 8892234 | ||
| Pubmed | TRPM6 SULT1A4 SULT1A1 SULT1A3 TRPM3 POLR2A DNAH2 SRMS PRKCB PLA2G4E SULT1C4 ULK2 | 5.90e-07 | 730 | 93 | 12 | 34857952 | |
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 12438748 | ||
| Pubmed | 6.43e-07 | 7 | 93 | 3 | 9370299 | ||
| Pubmed | PDIA4 TOX4 PTPN13 CEP85 TRIO TLE3 DNAJA2 POLR2A MIOS ELP1 SMPD4 AIP SIX4 CEMIP2 | 7.66e-07 | 1049 | 93 | 14 | 27880917 | |
| Pubmed | A comparison of Notch, Hes and Grg expression during murine embryonic and post-natal development. | 1.03e-06 | 8 | 93 | 3 | 10512199 | |
| Pubmed | Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. | 1.03e-06 | 8 | 93 | 3 | 10594240 | |
| Pubmed | Nolz1 promotes striatal neurogenesis through the regulation of retinoic acid signaling. | 1.03e-06 | 8 | 93 | 3 | 20735826 | |
| Pubmed | 1.54e-06 | 9 | 93 | 3 | 8887328 | ||
| Pubmed | 1.54e-06 | 9 | 93 | 3 | 19548878 | ||
| Pubmed | 1.54e-06 | 9 | 93 | 3 | 9177785 | ||
| Pubmed | 1.54e-06 | 9 | 93 | 3 | 9166597 | ||
| Pubmed | 1.54e-06 | 9 | 93 | 3 | 8468045 | ||
| Pubmed | Chromosomal localization of the mouse genes encoding the ERK1 and ERK2 isoforms of MAP kinases. | 1.54e-06 | 9 | 93 | 3 | 9060415 | |
| Pubmed | Human cytosolic sulphotransferases: genetics, characteristics, toxicological aspects. | 2.19e-06 | 10 | 93 | 3 | 11535246 | |
| Pubmed | 2.19e-06 | 10 | 93 | 3 | 30571765 | ||
| Pubmed | 3.01e-06 | 11 | 93 | 3 | 22439931 | ||
| Pubmed | Localization of the murine cholecystokinin A and B receptor genes. | 3.01e-06 | 11 | 93 | 3 | 7613026 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 3.01e-06 | 11 | 93 | 3 | 15499562 | |
| Pubmed | Tbx6, a mouse T-Box gene implicated in paraxial mesoderm formation at gastrulation. | 3.01e-06 | 11 | 93 | 3 | 8954725 | |
| Pubmed | 3.65e-06 | 153 | 93 | 6 | 10718198 | ||
| Pubmed | Identification of four chromosomal loci determining obesity in a multifactorial mouse model. | 4.00e-06 | 12 | 93 | 3 | 7706460 | |
| Pubmed | 5.19e-06 | 13 | 93 | 3 | 10585447 | ||
| Pubmed | 5.19e-06 | 13 | 93 | 3 | 22735158 | ||
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | PDS5B PTPN13 CEP85 ZBED4 TRIO RBBP6 TLE1 DNAJA2 POLR2A EZH2 ARHGAP21 RFWD3 | 6.52e-06 | 922 | 93 | 12 | 27609421 |
| Pubmed | 6.60e-06 | 14 | 93 | 3 | 17202186 | ||
| Pubmed | Active site mutations and substrate inhibition in human sulfotransferase 1A1 and 1A3. | 7.07e-06 | 2 | 93 | 2 | 14871892 | |
| Pubmed | Genotype of metabolic enzymes and the benefit of tamoxifen in postmenopausal breast cancer patients. | 7.07e-06 | 2 | 93 | 2 | 15987423 | |
| Pubmed | Role of Conformational Dynamics of Sulfotransferases SULT1A1 and SULT1A3 in Substrate Specificity. | 7.07e-06 | 2 | 93 | 2 | 38069221 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 12761191 | ||
| Pubmed | Effects of CYP2D6 and SULT1A1 genotypes including SULT1A1 gene copy number on tamoxifen metabolism. | 7.07e-06 | 2 | 93 | 2 | 17947222 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 29705271 | ||
| Pubmed | Grg1 acts as a lung-specific oncogene in a transgenic mouse model. | 7.07e-06 | 2 | 93 | 2 | 16452182 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 19073827 | ||
| Pubmed | Cloning and expression of a novel form of leukotriene B4 omega-hydroxylase from human liver. | 7.07e-06 | 2 | 93 | 2 | 8026587 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 37558192 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 10543947 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 15752422 | ||
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 10831834 | ||
| Pubmed | Human liver thermolabile phenol sulfotransferase: cDNA cloning, expression and characterization. | 7.07e-06 | 2 | 93 | 2 | 8117269 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 8093002 | ||
| Pubmed | Differential functions of TLE1 and TLE3 depending on a specific phosphorylation site. | 7.07e-06 | 2 | 93 | 2 | 33571907 | |
| Pubmed | 7.07e-06 | 2 | 93 | 2 | 31145702 | ||
| Pubmed | 8.23e-06 | 15 | 93 | 3 | 1741163 | ||
| Pubmed | 8.23e-06 | 15 | 93 | 3 | 9291577 | ||
| Pubmed | 1.47e-05 | 18 | 93 | 3 | 33658226 | ||
| Pubmed | 1.47e-05 | 18 | 93 | 3 | 22434868 | ||
| Pubmed | 1.47e-05 | 18 | 93 | 3 | 11731482 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 7695643 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 10825294 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 22354967 | ||
| Pubmed | Human CYP4F3s are the main catalysts in the oxidation of fatty acid epoxides. | 2.12e-05 | 3 | 93 | 2 | 15145985 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 22305566 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 12030375 | ||
| Pubmed | In silico mechanistic profiling to probe small molecule binding to sulfotransferases. | 2.12e-05 | 3 | 93 | 2 | 24039991 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 20309015 | ||
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 31669648 | ||
| Pubmed | Tle corepressors are differentially partitioned to instruct CD8+ T cell lineage choice and identity. | 2.12e-05 | 3 | 93 | 2 | 30045946 | |
| Pubmed | TLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cells. | 2.12e-05 | 3 | 93 | 2 | 22952044 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 36053032 | ||
| Pubmed | HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer. | 2.12e-05 | 3 | 93 | 2 | 31636385 | |
| Pubmed | 2.12e-05 | 3 | 93 | 2 | 8912648 | ||
| Interaction | SULT1A4 interactions | 3.60e-07 | 14 | 90 | 4 | int:SULT1A4 | |
| Interaction | SULT1C2 interactions | 1.37e-06 | 19 | 90 | 4 | int:SULT1C2 | |
| Interaction | RIPPLY2 interactions | 1.71e-06 | 20 | 90 | 4 | int:RIPPLY2 | |
| Interaction | TLE2 interactions | 2.56e-06 | 136 | 90 | 7 | int:TLE2 | |
| Interaction | SULT1A3 interactions | 3.69e-06 | 24 | 90 | 4 | int:SULT1A3 | |
| Interaction | RIPPLY3 interactions | 1.10e-05 | 112 | 90 | 6 | int:RIPPLY3 | |
| Interaction | SIX6 interactions | 1.38e-05 | 11 | 90 | 3 | int:SIX6 | |
| Interaction | HLX interactions | 2.19e-05 | 37 | 90 | 4 | int:HLX | |
| Interaction | PRDM1 interactions | 3.71e-05 | 84 | 90 | 5 | int:PRDM1 | |
| Interaction | TLE1 interactions | 4.75e-05 | 213 | 90 | 7 | int:TLE1 | |
| Interaction | SIX4 interactions | 5.26e-05 | 46 | 90 | 4 | int:SIX4 | |
| Interaction | FOXG1 interactions | 6.70e-05 | 95 | 90 | 5 | int:FOXG1 | |
| Interaction | FOXA3 interactions | 8.55e-05 | 52 | 90 | 4 | int:FOXA3 | |
| Interaction | SMG7 interactions | 9.08e-05 | 319 | 90 | 8 | int:SMG7 | |
| Interaction | SIX3 interactions | 9.29e-05 | 20 | 90 | 3 | int:SIX3 | |
| Interaction | CSTF2 interactions | 9.70e-05 | 165 | 90 | 6 | int:CSTF2 | |
| Interaction | RIPPLY1 interactions | 1.07e-04 | 55 | 90 | 4 | int:RIPPLY1 | |
| Interaction | AOPEP interactions | 1.08e-04 | 21 | 90 | 3 | int:AOPEP | |
| Interaction | MSANTD3 interactions | 1.08e-04 | 21 | 90 | 3 | int:MSANTD3 | |
| Interaction | EYA1 interactions | 1.40e-04 | 59 | 90 | 4 | int:EYA1 | |
| Interaction | CSNK1D interactions | 1.43e-04 | 254 | 90 | 7 | int:CSNK1D | |
| Interaction | GATA3 interactions | 1.92e-04 | 187 | 90 | 6 | int:GATA3 | |
| Interaction | CYP4F3 interactions | 1.96e-04 | 5 | 90 | 2 | int:CYP4F3 | |
| Interaction | NFIA interactions | 1.98e-04 | 188 | 90 | 6 | int:NFIA | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9q21 | 7.40e-04 | 199 | 93 | 4 | chr9q21 | |
| Cytoband | 12q21.2 | 7.53e-04 | 20 | 93 | 2 | 12q21.2 | |
| Cytoband | 9q21.13 | 1.18e-03 | 25 | 93 | 2 | 9q21.13 | |
| Cytoband | 17p13.1 | 1.81e-03 | 118 | 93 | 3 | 17p13.1 | |
| GeneFamily | Sulfotransferases, cytosolic | 8.68e-08 | 14 | 57 | 4 | 762 | |
| GeneFamily | Dyneins, axonemal | 1.29e-03 | 17 | 57 | 2 | 536 | |
| GeneFamily | WD repeat domain containing | 1.39e-03 | 262 | 57 | 5 | 362 | |
| GeneFamily | Protein disulfide isomerases | 1.97e-03 | 21 | 57 | 2 | 692 | |
| GeneFamily | Transient receptor potential cation channels | 3.50e-03 | 28 | 57 | 2 | 249 | |
| GeneFamily | Cytochrome P450 family 4 | 5.74e-03 | 36 | 57 | 2 | 1003 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 9.80e-07 | 219 | 91 | 8 | M41199 | |
| ToppCell | IPF-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 1.54e-07 | 193 | 92 | 7 | ad58f5080e0ba65c845056ea6b79037b636e9c64 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 2.16e-06 | 182 | 92 | 6 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 2.60e-06 | 188 | 92 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Children_(3_yrs)-Epithelial-ciliated_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.68e-06 | 189 | 92 | 6 | 68a3cf7763d6f9b95d6d6524eff7a16042703f1d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.12e-06 | 194 | 92 | 6 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.23e-05 | 144 | 92 | 5 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-05 | 164 | 92 | 5 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.37e-05 | 165 | 92 | 5 | 4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.60e-05 | 180 | 92 | 5 | 0c146e80d55d18b6988dd21b1da635801bd3140c | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.60e-05 | 180 | 92 | 5 | e9af22beae2f3c7fe213b4e19df84abfd2453433 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.60e-05 | 180 | 92 | 5 | 11455ba704ac73f69b474845136cfecec6a88349 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 3.69e-05 | 181 | 92 | 5 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 181 | 92 | 5 | 41969fe4d94ee77b12ecde32170aaf0b13e49644 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 181 | 92 | 5 | 57f0cc749ae8b6a3d77e2af31f9a6e4739c57049 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 181 | 92 | 5 | 3f50e61dc2a52d71a5801584617607e6246adcf2 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.69e-05 | 181 | 92 | 5 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.69e-05 | 181 | 92 | 5 | d01b35cc2fc57991a35be6a06cb7351fbabd9a11 | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.10e-05 | 185 | 92 | 5 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.10e-05 | 185 | 92 | 5 | 3e39a3cb534dfe2301930f3e2f7e8cefb522c158 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 4.10e-05 | 185 | 92 | 5 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.31e-05 | 187 | 92 | 5 | 9e10ed56090d82589bc457788282f664b70ace4b | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.42e-05 | 188 | 92 | 5 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 4.54e-05 | 189 | 92 | 5 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 4.54e-05 | 189 | 92 | 5 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 4.54e-05 | 189 | 92 | 5 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-Ciliated_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-05 | 190 | 92 | 5 | e243b5fbb17b9ec3cc90bbe970c1d30b0fd1c2e1 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.65e-05 | 190 | 92 | 5 | 0db545a4cba7534bad2693e0d565cde7dbc7a586 | |
| ToppCell | facs-Lung-nan-3m-Epithelial-ciliated_columnar_cell_of_tracheobronchial_tree|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-05 | 190 | 92 | 5 | fe844559b95832845d2e8d3ab4b57e3d558bc372 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.77e-05 | 191 | 92 | 5 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.77e-05 | 191 | 92 | 5 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.77e-05 | 191 | 92 | 5 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 5.01e-05 | 193 | 92 | 5 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.14e-05 | 194 | 92 | 5 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-05 | 194 | 92 | 5 | e8102c8811333f04de7280b7d9b6b85cebb815ac | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.14e-05 | 194 | 92 | 5 | 4b0d63babb8a46ff45731d5f82b29ccaf6c9402d | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.26e-05 | 195 | 92 | 5 | d8fa96c8f14bd088c3f8bd14f894a2c5b7ad46a7 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.26e-05 | 195 | 92 | 5 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.66e-05 | 198 | 92 | 5 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | LPS_anti-TNF-Epithelial_airway-airway_epithelial-Airway-Club|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 5.66e-05 | 198 | 92 | 5 | 6712216c5a7fd86b68fd45b0ff7794975f19774e | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-1m-Mesenchymal-Cilia-bearing_cell|1m / Sample Type, Dataset, Time_group, and Cell type. | 5.79e-05 | 199 | 92 | 5 | fd91fdc76decd5876d5e914d68134282aba9c4c8 | |
| ToppCell | Sepsis-URO-Myeloid-pDC|URO / Disease, condition lineage and cell class | 5.79e-05 | 199 | 92 | 5 | 1dc96a1cc313fa175fe50f0df606baa84ea5970b | |
| ToppCell | Sepsis-Int-URO-Myeloid-pDC|Int-URO / Disease, condition lineage and cell class | 5.79e-05 | 199 | 92 | 5 | a41c3c3360b1b4546c9b2c49bda595feef6a4a4a | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial-Ciliated|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.93e-05 | 200 | 92 | 5 | 96701a4d57753f5ec0dd5c7550054bbcc946bc5f | |
| ToppCell | Sepsis-ICU-NoSEP-Lymphocyte-T/NK-NK_CD56bright|ICU-NoSEP / Disease, condition lineage and cell class | 5.93e-05 | 200 | 92 | 5 | c2df917900872453ea17a39928e39d071a6d3339 | |
| ToppCell | mLN-Dendritic_cell-pDC|Dendritic_cell / Region, Cell class and subclass | 5.93e-05 | 200 | 92 | 5 | 10ae1ac8a98346320a92e855aebb3a7109f0ab9b | |
| ToppCell | COVID-19-kidney-Epithelial_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.12e-04 | 120 | 92 | 4 | e17c85d41c781a29dec7e03a8b0637dccb4346bc | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.42e-04 | 49 | 92 | 3 | 1002c6f5cfc09eb5cf882e0cf366d9ba8e456a57 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-B_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.42e-04 | 49 | 92 | 3 | d7fc93efa70b464da39192e4bd8b1e8ad19bbec1 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.82e-04 | 136 | 92 | 4 | 47663c5d81c766a333207a44fc5b58b07309ee76 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.82e-04 | 136 | 92 | 4 | 6d2e5b871f4cf8d64e6fe0be666fb3490797c635 | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.82e-04 | 136 | 92 | 4 | fd4269d194c7c11c6ab4383393a01efab05cbace | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.82e-04 | 136 | 92 | 4 | 3f6cec8d52c84191f7f6e2dd4dc47524dfd5b21b | |
| ToppCell | Substantia_nigra-Macroglia-CSF_related-EPENDYMAL-Ependyma.Ccdc153_(Ccdc153)-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.82e-04 | 136 | 92 | 4 | 67d736096d6b6ddb4722809557f5e987063b8d23 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_Invariant-Inducer-like-MAIT|GI_small-bowel / Manually curated celltypes from each tissue | 2.44e-04 | 147 | 92 | 4 | 4ba9a86ab7033688a9a2a2dc84c001a49af835b4 | |
| ToppCell | Mild/Remission-B_naive-4|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.51e-04 | 148 | 92 | 4 | dd5e1bc02824e743e1c030a303e32f27a359a8ca | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-3|TCGA-Brain / Sample_Type by Project: Shred V9 | 2.57e-04 | 149 | 92 | 4 | 768877bade04ca0321593b8470b5011ad8270431 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.78e-04 | 152 | 92 | 4 | 0652ee3443e6fbb679d2c4f326239ae7c803f924 | |
| ToppCell | IIH-Treg|IIH / Condition, Cell_class and T cell subcluster | 2.85e-04 | 153 | 92 | 4 | 17704e18833812fcf2a2727b1e3f8a9984ba5b59 | |
| ToppCell | IIH-Treg-CD4_Treg|IIH / Condition, Cell_class and T cell subcluster | 2.92e-04 | 154 | 92 | 4 | d2211a892654b92decb208969040920f7ae8ba1e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.07e-04 | 156 | 92 | 4 | 955547dfeb1b1ad4957b4338701055726b22619f | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-Tfh|Liver / Manually curated celltypes from each tissue | 3.07e-04 | 156 | 92 | 4 | 85bc34ff507f9a66c6e3ba7a3ffd5416d0073ccf | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.14e-04 | 157 | 92 | 4 | 2c5295043611bac7dfa4aef2146681bce4a33a8f | |
| ToppCell | LAM-Lymphoid-pDC|LAM / Condition, Lineage and Cell class | 3.45e-04 | 161 | 92 | 4 | bb5b44713e4da4406cdaa79dcf2aa9f97e3cf75a | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-04 | 161 | 92 | 4 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | T_cells-Tph_and_Tfh|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 3.54e-04 | 162 | 92 | 4 | 146058f2d60846376078916055d08f68562e3a7c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.62e-04 | 163 | 92 | 4 | 6bed27d2f67a430a847da5eb47878d14b4949c45 | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.62e-04 | 163 | 92 | 4 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 | |
| ToppCell | NS-control-d_0-4-Myeloid-pDC|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.79e-04 | 165 | 92 | 4 | 8b2d43d7c4ee07bd999bd51bc15117ce1fbb2d86 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-Plasma_cells_and_B_cells|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-04 | 165 | 92 | 4 | 21a82a975f550080b6674750b06212205cd16742 | |
| ToppCell | control-Myeloid-pDC|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.79e-04 | 165 | 92 | 4 | 243c74adf8d993ff92acbff2768bdc5a1693eca3 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.88e-04 | 166 | 92 | 4 | c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.97e-04 | 167 | 92 | 4 | 859dfe0764cb69de27e79e1c1aa65f9d538f79ea | |
| ToppCell | Control-Epithelial_airway-Club_cells-Airway|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-04 | 168 | 92 | 4 | ce87981f4da2779de952c2e5d2bbcdabb265e705 | |
| ToppCell | healthy_donor-Myeloid-Monocytic-Neutrophil|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.06e-04 | 168 | 92 | 4 | 04259f5a9b067cd1b5619e34591e4b2fccc18535 | |
| ToppCell | B_cells-pDCs|World / Immune cells in Kidney/Urine in Lupus Nephritis | 4.06e-04 | 168 | 92 | 4 | dc8f94424f60ab56facdcffa969e7f3466ee1b6e | |
| ToppCell | Control-Epithelial_airway-Club_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.06e-04 | 168 | 92 | 4 | e85bc5398eb36b2b0773a8a7082e3ba740452165 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-04 | 169 | 92 | 4 | b253a4a50c06d36228fcd5d856c57202cbac158f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.15e-04 | 169 | 92 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-04 | 170 | 92 | 4 | 8e1f757ed62218c0fb6525f49d142dd2cd29acf9 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.24e-04 | 170 | 92 | 4 | b49f7c8a27078de2137ed04f74cfee30729cfa5e | |
| ToppCell | facs-Lung-nan-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-04 | 170 | 92 | 4 | 67d7e1da3ebd2d14cb2e67799e94d655027ed5c4 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-club_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.24e-04 | 170 | 92 | 4 | 6de3778e8257c3330db0780c59238ca501fe5059 | |
| ToppCell | facs-Lung-3m-Epithelial-airway_epithelial-club_cell-club_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.24e-04 | 170 | 92 | 4 | 60887da674ef1a735bad618235608312d8de63d3 | |
| ToppCell | Immune-dendritic_cell|World / Lineage, Cell type, age group and donor | 4.34e-04 | 171 | 92 | 4 | 6a9e2e2d3e1d8cc475bf9765129bc4a32da3b8ea | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.34e-04 | 171 | 92 | 4 | c2dbc439af28d4fabb24d57685b75b2e588819b0 | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.34e-04 | 171 | 92 | 4 | 6a5ac0f56bd7b4543be103100fb735ca6bc5b8bf | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.43e-04 | 172 | 92 | 4 | a9e13aa36087170dadca421ba9de588e5a1cf715 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Hematopoietic-Myeloid-pDC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.43e-04 | 172 | 92 | 4 | b84610f1e5889a655652800c2b3270d264bfe1a9 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.53e-04 | 173 | 92 | 4 | 8335b77f730ed43fc348a005566e73a103c6774b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.53e-04 | 173 | 92 | 4 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 173 | 92 | 4 | e0cf99ddbe6e9eab05d7bf89e9aa124850c6a807 | |
| ToppCell | 10x5'-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid|bone_marrow / Manually curated celltypes from each tissue | 4.53e-04 | 173 | 92 | 4 | 5645a3b1e805c71d5d65fc8e4edc4e13208063fc | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-Unknown_Progenitor|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 174 | 92 | 4 | 3b1ee39e85e5f0d6b17fb3051dbfae66cb2be6ee | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.63e-04 | 174 | 92 | 4 | ae363ce736fc8af439f3ad594d7bc2e344db80d4 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.63e-04 | 174 | 92 | 4 | cdfc50e5383c8670ce5109736aff36406f46c03d | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-04 | 175 | 92 | 4 | 4be01bf30331162f1998216fb2871a4e626dc440 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L6_FEZF2_FAM95C|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.73e-04 | 175 | 92 | 4 | 90e29945aa861082c94bb4f331161adc3a6ef899 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.73e-04 | 175 | 92 | 4 | f3a68aeb79c4935006e17a5ff3445a8ec0e33f5f | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.73e-04 | 175 | 92 | 4 | 1c7725f917f3d6b9e0a31ede9524690f408a5ea1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.84e-04 | 176 | 92 | 4 | 8488997e0f02e874f53fae1690da63e0dd1d0780 | |
| Drug | Harmaline hydrochloride dihydrate [6027-98-1]; Down 200; 14uM; MCF7; HT_HG-U133A | 9.59e-07 | 188 | 92 | 8 | 2805_DN | |
| Drug | tyramine | 9.85e-07 | 130 | 92 | 7 | CID000005610 | |
| Drug | 4-octylphenol | 1.29e-06 | 47 | 92 | 5 | CID000015730 | |
| Drug | p-nitroanisole | 1.99e-06 | 92 | 92 | 6 | CID000007485 | |
| Drug | dopamine-4-O-sulfate | 2.21e-06 | 7 | 92 | 3 | CID000123932 | |
| Drug | 2-naphthylsulfate | 2.21e-06 | 7 | 92 | 3 | CID000074428 | |
| Drug | 2-iodo-4-azidophenol | 2.21e-06 | 7 | 92 | 3 | CID003035977 | |
| Drug | luciferyl sulfate | 2.21e-06 | 7 | 92 | 3 | CID011953812 | |
| Drug | alpha-methyldopamine | 3.49e-06 | 26 | 92 | 4 | CID000017005 | |
| Drug | dopamine 3-O-sulfate | 3.52e-06 | 8 | 92 | 3 | CID000122136 | |
| Drug | 2-amino-1-methyl-6-(4-hydroxyphenyl)imidazo(4,5-b)pyridine | 3.52e-06 | 8 | 92 | 3 | ctd:C077584 | |
| Drug | 6-anilino-2-thiouracil | 3.52e-06 | 8 | 92 | 3 | CID003037707 | |
| Drug | 2-iodophenol | 3.52e-06 | 8 | 92 | 3 | CID000010784 | |
| Drug | barium hydroxide | 7.22e-06 | 31 | 92 | 4 | CID000028387 | |
| Drug | Capsaicin [404-86-4]; Down 200; 13uM; PC3; HT_HG-U133A | 1.39e-05 | 194 | 92 | 7 | 4612_DN | |
| Drug | E)-4-hydroxytamoxifen | 1.54e-05 | 197 | 92 | 7 | CID000063062 | |
| Drug | Hydroxytryptophol | 1.62e-05 | 2 | 92 | 2 | ctd:D006917 | |
| Drug | 6-hydroxymelatonin | 1.62e-05 | 2 | 92 | 2 | ctd:C012365 | |
| Drug | EM-139 | 1.77e-05 | 13 | 92 | 3 | CID000131427 | |
| Drug | naphthalenemethanol | 2.25e-05 | 14 | 92 | 3 | CID000020908 | |
| Drug | deoxoestrone | 2.25e-05 | 14 | 92 | 3 | CID000005888 | |
| Drug | arylsulfate | 2.80e-05 | 15 | 92 | 3 | CID000074426 | |
| Drug | cyclobenzaprine | 2.80e-05 | 15 | 92 | 3 | CID000002895 | |
| Drug | NDPS | 3.28e-05 | 45 | 92 | 4 | CID000090363 | |
| Drug | A-44 | 3.44e-05 | 16 | 92 | 3 | CID000120353 | |
| Drug | halothane | 4.08e-05 | 314 | 92 | 8 | CID000003562 | |
| Drug | benzilic acid | 4.17e-05 | 17 | 92 | 3 | CID000006463 | |
| Drug | sulfamethazine | 4.24e-05 | 48 | 92 | 4 | CID000005327 | |
| Drug | N-hydroxy-2-acetylaminofluorene | 4.24e-05 | 48 | 92 | 4 | CID000005896 | |
| Drug | 8-azaadenine | 4.83e-05 | 3 | 92 | 2 | ctd:C006654 | |
| Drug | 3,3'-diiodothyronine | 4.83e-05 | 3 | 92 | 2 | ctd:C030629 | |
| Drug | 5-hydroxyindole | 4.83e-05 | 3 | 92 | 2 | ctd:C026785 | |
| Drug | Minoxidil | 4.83e-05 | 3 | 92 | 2 | ctd:D008914 | |
| Drug | AC1Q6OHG | 5.90e-05 | 19 | 92 | 3 | CID000115063 | |
| Drug | pedunculagin | 5.90e-05 | 19 | 92 | 3 | CID000442688 | |
| Drug | 9-hydroxybenzo(a)pyrene | 6.28e-05 | 53 | 92 | 4 | CID000028598 | |
| Drug | minoxidil | 6.76e-05 | 54 | 92 | 4 | CID000004201 | |
| Drug | A21250 | 6.78e-05 | 105 | 92 | 5 | CID000000990 | |
| Drug | PLP-Glu | 6.92e-05 | 20 | 92 | 3 | CID000444293 | |
| Drug | N-hydroxy-2-aminofluorene | 8.06e-05 | 21 | 92 | 3 | CID000005895 | |
| Drug | MeA alpha C | 9.30e-05 | 22 | 92 | 3 | CID000062244 | |
| Drug | AABSSN | 9.30e-05 | 22 | 92 | 3 | CID005464134 | |
| Drug | 2-acetylaminofluorene | 9.40e-05 | 262 | 92 | 7 | CID000005897 | |
| Drug | AC1L955D | 9.64e-05 | 4 | 92 | 2 | CID000438204 | |
| Drug | 9a-d | 9.64e-05 | 4 | 92 | 2 | CID000128962 | |
| Drug | 3'-oxoadenosine | 9.64e-05 | 4 | 92 | 2 | CID000446824 | |
| Drug | 17-ODYA | 1.02e-04 | 60 | 92 | 4 | CID000001449 | |
| Drug | taselin | 1.07e-04 | 23 | 92 | 3 | CID000023846 | |
| Drug | AalphaC | 1.22e-04 | 24 | 92 | 3 | CID000062805 | |
| Drug | Promazine hydrochloride [53-60-1]; Down 200; 12.4uM; MCF7; HT_HG-U133A | 1.23e-04 | 190 | 92 | 6 | 3833_DN | |
| Drug | Econazole nitrate [24169-02-6]; Down 200; 9uM; PC3; HT_HG-U133A | 1.23e-04 | 190 | 92 | 6 | 7305_DN | |
| Drug | Benzylpenicillin sodium [69-57-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.26e-04 | 191 | 92 | 6 | 6839_DN | |
| Drug | pentachlorophenol | 1.28e-04 | 120 | 92 | 5 | CID000000992 | |
| Drug | Pseudopelletierine hydrochloride [6164-62-1]; Down 200; 21uM; MCF7; HT_HG-U133A | 1.30e-04 | 192 | 92 | 6 | 2766_DN | |
| Drug | 4-nonylphenol | 1.32e-04 | 64 | 92 | 4 | CID000001752 | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | 1.34e-04 | 193 | 92 | 6 | 5922_UP | |
| Drug | AzMC | 1.38e-04 | 25 | 92 | 3 | CID000064986 | |
| Drug | minoxidil sulphate | 1.38e-04 | 25 | 92 | 3 | CID000004202 | |
| Drug | 2-pentanone | 1.38e-04 | 25 | 92 | 3 | CID000007895 | |
| Drug | ebastine | 1.38e-04 | 25 | 92 | 3 | CID000003191 | |
| Drug | epicatechin-3-gallate | 1.40e-04 | 65 | 92 | 4 | CID000065056 | |
| Drug | ST021200; Down 200; 10uM; PC3; HT_HG-U133A | 1.41e-04 | 195 | 92 | 6 | 7493_DN | |
| Drug | Fursultiamine Hydrochloride [2105-43-3]; Down 200; 9.2uM; HL60; HT_HG-U133A | 1.41e-04 | 195 | 92 | 6 | 2929_DN | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 1.41e-04 | 195 | 92 | 6 | 5359_DN | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.45e-04 | 196 | 92 | 6 | 5765_DN | |
| Drug | Dipivefrin hydrochloride [64019-93-8]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.45e-04 | 196 | 92 | 6 | 7124_DN | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; PC3; HT_HG-U133A | 1.50e-04 | 197 | 92 | 6 | 3717_UP | |
| Drug | Ethotoin [86-35-1]; Up 200; 19.6uM; PC3; HT_HG-U133A | 1.50e-04 | 197 | 92 | 6 | 4545_UP | |
| Drug | Chicago sky blue 6B [2610-05-1]; Down 200; 4uM; MCF7; HT_HG-U133A | 1.54e-04 | 198 | 92 | 6 | 4971_DN | |
| Drug | tolbutamide | 1.54e-04 | 198 | 92 | 6 | CID000005505 | |
| Drug | glycolithocholic acid | 1.55e-04 | 26 | 92 | 3 | CID000115245 | |
| Drug | 1m2q | 1.55e-04 | 26 | 92 | 3 | CID005326637 | |
| Drug | Practolol [6673-35-4]; Down 200; 15uM; PC3; HT_HG-U133A | 1.58e-04 | 199 | 92 | 6 | 4603_DN | |
| Drug | Proparacaine hydrochloride [5875-06-9]; Up 200; 12uM; MCF7; HT_HG-U133A | 1.58e-04 | 199 | 92 | 6 | 5433_UP | |
| Drug | Bethanechol chloride [590-63-6]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 1.58e-04 | 199 | 92 | 6 | 5539_UP | |
| Drug | chlorpromazine hydrochloride; Up 200; 1uM; HL60; HT_HG-U133A | 1.58e-04 | 199 | 92 | 6 | 2677_UP | |
| Drug | Trichlorfon [52-68-6]; Up 200; 15.6uM; PC3; HT_HG-U133A | 1.58e-04 | 199 | 92 | 6 | 1797_UP | |
| Drug | harmol | 1.60e-04 | 5 | 92 | 2 | ctd:C001326 | |
| Drug | pinocembrin | 1.60e-04 | 5 | 92 | 2 | ctd:C016063 | |
| Drug | adenylylsulfate | 2.08e-04 | 72 | 92 | 4 | CID000000228 | |
| Drug | Glu-P-2 | 2.16e-04 | 29 | 92 | 3 | CID000049970 | |
| Drug | 3,3'-T2 | 2.40e-04 | 30 | 92 | 3 | CID000065559 | |
| Drug | rifampicin | 2.44e-04 | 306 | 92 | 7 | CID005381226 | |
| Drug | A2'p5'A2'p5'A | 2.64e-04 | 31 | 92 | 3 | CID000122642 | |
| Drug | acetaminophen sulfate | 2.64e-04 | 31 | 92 | 3 | CID000083939 | |
| Drug | AC1L1HQG | 2.80e-04 | 142 | 92 | 5 | CID000004246 | |
| Drug | aniline | 2.80e-04 | 142 | 92 | 5 | CID000006115 | |
| Drug | benzyloxyresorufin | 2.83e-04 | 78 | 92 | 4 | CID000114982 | |
| Drug | DCNP | 3.19e-04 | 33 | 92 | 3 | CID000012066 | |
| Drug | 1-naphthol | 3.19e-04 | 33 | 92 | 3 | ctd:C029350 | |
| Drug | Phosphoadenosine Phosphosulfate | 3.35e-04 | 7 | 92 | 2 | ctd:D010724 | |
| Drug | mercury | 3.46e-04 | 542 | 92 | 9 | CID000023931 | |
| Disease | lung adenocarcinoma (is_implicated_in) | 1.23e-05 | 49 | 85 | 4 | DOID:3910 (is_implicated_in) | |
| Disease | cardiovascular system disease (is_implicated_in) | 2.96e-05 | 21 | 85 | 3 | DOID:1287 (is_implicated_in) | |
| Disease | Rickets | 8.15e-05 | 5 | 85 | 2 | cv:C0035579 | |
| Disease | Hypophosphatemic rickets | 8.15e-05 | 5 | 85 | 2 | cv:C1704375 | |
| Disease | Hereditary hypophosphatemic rickets | 8.15e-05 | 5 | 85 | 2 | cv:CN296404 | |
| Disease | response to atorvastatin, myopathy | 6.27e-04 | 13 | 85 | 2 | EFO_0004145, EFO_0010124 | |
| Disease | oral squamous cell carcinoma (is_marker_for) | 8.09e-04 | 63 | 85 | 3 | DOID:0050866 (is_marker_for) | |
| Disease | Mammary Carcinoma, Human | 8.09e-04 | 525 | 85 | 7 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 8.09e-04 | 525 | 85 | 7 | C1257931 | |
| Disease | Mammary Neoplasms | 8.28e-04 | 527 | 85 | 7 | C1458155 | |
| Disease | Generalized hypotonia | 8.40e-04 | 15 | 85 | 2 | C1858120 | |
| Disease | Breast Carcinoma | 9.33e-04 | 538 | 85 | 7 | C0678222 | |
| Disease | colorectal adenoma (is_marker_for) | 1.51e-03 | 20 | 85 | 2 | DOID:0050860 (is_marker_for) | |
| Disease | otitis media (implicated_via_orthology) | 1.82e-03 | 22 | 85 | 2 | DOID:10754 (implicated_via_orthology) | |
| Disease | lung adenocarcinoma (is_marker_for) | 1.92e-03 | 85 | 85 | 3 | DOID:3910 (is_marker_for) | |
| Disease | glioblastoma (is_implicated_in) | 2.17e-03 | 24 | 85 | 2 | DOID:3068 (is_implicated_in) | |
| Disease | lung squamous cell carcinoma (is_implicated_in) | 2.17e-03 | 24 | 85 | 2 | DOID:3907 (is_implicated_in) | |
| Disease | mean platelet volume | 2.67e-03 | 1020 | 85 | 9 | EFO_0004584 | |
| Disease | chronic myeloid leukemia (is_marker_for) | 2.75e-03 | 27 | 85 | 2 | DOID:8552 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GLYHLKQINSPMMTV | 771 | Q13075 | |
| HGSPVKMMESYIAVL | 116 | Q6NSW5 | |
| PKNLMQTLMEDYETH | 801 | Q9Y2D5 | |
| PTVGMKRSEQLMDYH | 451 | Q9P2B7 | |
| NVLQMLEAHMQSYKG | 6 | O43683 | |
| AVQPQEMSQMKPHVY | 721 | Q9UKQ2 | |
| SQAFGTVHVYPDKMM | 306 | Q3LIE5 | |
| KAEEMNPYHNLESGM | 606 | Q8IWG1 | |
| HMEMLKVESPGTYQQ | 151 | O00170 | |
| QYMVPHNLETTERMK | 461 | Q9NTI5 | |
| NMKSSQYIPMHGKQI | 486 | Q6PCD5 | |
| ESLYFNPMMTNGVVH | 6 | Q9UJX4 | |
| VQMVHPKFYGIGENM | 106 | Q4G1C9 | |
| PVTMSGKYIMEEHDS | 3051 | Q2LD37 | |
| QNEVIGMHAAMKYIN | 261 | Q9BVA6 | |
| MVEDETVLHNIPYMG | 121 | Q15910 | |
| KQAPHLVQVVMGFMY | 271 | Q8NGK0 | |
| MHIFQPEISKSYGMN | 2276 | Q6ZR08 | |
| PQFSMNHYMKLVQGE | 201 | Q6P1A2 | |
| AHYDQQMGQKVQLPM | 331 | Q96PP8 | |
| HEITMPNQMVRIYKD | 166 | P78334 | |
| DAMRAVMESINPHKY | 821 | O95163 | |
| SHGIIDNKMYDPKMN | 271 | P22413 | |
| QSIMEHNVAYPKSMS | 551 | P05771 | |
| GDVSIIIYPMKNHMF | 1766 | Q2PPJ7 | |
| GPMLQAKMDEIGNHY | 446 | Q8WVV4 | |
| EMYQKMQSPHAKLEV | 316 | Q9NXE4 | |
| IKAMMSQSGHEYDPI | 131 | Q7Z6E9 | |
| VGKTTPQYMENMEQV | 216 | Q9BY11 | |
| LTSVYQPTEMALMHK | 366 | Q9NQ84 | |
| EINGHMTVTKMAEYD | 481 | Q5T6X5 | |
| SKHMDGQMTQENIFP | 276 | Q8IZL2 | |
| QVMTLPVGESYELHM | 306 | Q3MJ16 | |
| MMHPLKVSLEDLYNG | 116 | O60884 | |
| QEPERQYMHIGTMVE | 961 | Q08462 | |
| EHIMSMAPNLKAGYN | 296 | Q13099 | |
| FMGHFTKPQQLQEEM | 931 | Q5THR3 | |
| MGMVYALDHDPVENK | 511 | P01133 | |
| EMGDQAHMPYTTAVI | 346 | P10635 | |
| SYMDNVMSEVLGQKP | 796 | O15063 | |
| MAMQEKYPTEGISHV | 1 | Q6P2H3 | |
| MEVPDYEMVHQAGLT | 346 | Q49AR2 | |
| LSYVELKHMGQQQMG | 531 | Q9UHN6 | |
| KPYMKIFNESVNIMH | 161 | P78329 | |
| LIMNKASPEYEENMH | 166 | Q96DN0 | |
| GRPSYQEDTIKMIMN | 91 | Q587J8 | |
| IHPVSTMVKGMYGIE | 271 | P07195 | |
| KPYMKIFNESVNIMH | 161 | Q08477 | |
| SGYMMKQSPHMQEGI | 2056 | Q8NDH2 | |
| SMQQEKLDAMDIPHY | 3341 | Q8NDH2 | |
| VITMSMEHYNQPKSL | 1631 | O95180 | |
| HGSPVKMMESYIAVL | 116 | Q8TCE6 | |
| EGHTVLYIPAEAMNM | 216 | Q9P225 | |
| MQQMSDHRYDKLTVP | 201 | O94760 | |
| LVKQEMVNMPRGIYH | 781 | Q5VW36 | |
| IEDPGQAYVLGMTMH | 1046 | Q12923 | |
| PSTPVHLTNEMKNYM | 1186 | Q12923 | |
| QGQTGKLMYVMHNSE | 56 | Q9H944 | |
| GHMYMILTPSDIQIQ | 2211 | Q6ZRI0 | |
| AAKMIKGYMQQHNIP | 121 | P35680 | |
| SVMNMHEIYTVLNPG | 186 | Q9GZM7 | |
| LKQLMVIGMDVYHDP | 736 | Q8TC59 | |
| MKMLQAPESVLAEHY | 71 | O00746 | |
| IEMYEGSHVPLEQMS | 186 | Q86UY8 | |
| NAPSSMMVKDEYVHD | 151 | Q13485 | |
| SHMEPVYMQQIGNAK | 326 | Q9UIU6 | |
| KYEPRSHMMDVQGST | 366 | P13667 | |
| PYEGMTNHETLQQIM | 426 | Q9H3Y6 | |
| PMTNYTTVPQELMDH | 236 | P0DMN0 | |
| PMTNYTTVPQELMDH | 236 | P0DMM9 | |
| EMSYGLNIEMHKQAE | 66 | Q08117 | |
| EMSYGLNIEMHKQTE | 66 | Q04724 | |
| PAQRTMHKDVMLETY | 46 | P51786 | |
| SQMYPGMRSQEVTKI | 126 | P0CB48 | |
| QHAGPYVTMIAKMTA | 961 | Q9BX84 | |
| HFMKQYTEDMDQKSP | 431 | Q9NXC5 | |
| PMTNYTTVPQEFMDH | 236 | P50225 | |
| MPYMSQAQEIHLQEK | 821 | Q9HCF6 | |
| MTLQGIEQISKVYMH | 1296 | P24928 | |
| VHYTSFDVMKQNPMA | 231 | O75897 | |
| ETHKLMYDNTSEMPG | 1046 | Q8IWV7 | |
| IPHENRTSEAMYNKM | 286 | P78562 | |
| HLQPMEGQMYEITED | 371 | Q6N022 | |
| AMEPSYELIHTQMKT | 2496 | Q6N022 | |
| YGLVLQVPMMHQTTE | 216 | A8MV23 | |
| EMSYGLNIEMHKQTE | 66 | Q04726 | |
| HLSMVVQLMKYGADP | 136 | Q8IUH5 | |
| MAPEVIMSQHYDAKA | 181 | Q8IYT8 | |
| HITPMQYKAMQAAGQ | 101 | P26368 | |
| GIAKAHQMMLTVNNY | 401 | Q8NA56 | |
| TMDNTKHILNYLMPI | 181 | Q96BZ9 | |
| PYTTDMHLVTNSGKM | 471 | O60264 | |
| HMVTHMPDQYKIVET | 1316 | Q5T5U3 | |
| MSYGLNIEMHKQAEI | 66 | Q04725 | |
| QYGVQTLDMPVGMTH | 76 | O94842 | |
| KYLHRNSVNMPGMVT | 1086 | O75962 | |
| PGMYDNVKQIIMSHL | 706 | O75132 | |
| VMQGVQTPYLHLSAM | 576 | Q5VV43 |